Breast and prostate cancer patients may have new hope, with a study in the Expert Opinion on Investigational Drugs journal suggesting that cannabinoids from marijuana can help treat the illnesses. The research was initially published online, but is also due to go to print in the U.S. National Institute of Health journal.
The in-depth study has yielded plenty of promising results, with its abstract indicating that phytocannabinoids have a number of chemotherapeutic effects. Endocannabinoids (those already in the body) and synthetic cannabinoids which have been specially formulated have also shown signs of effectiveness against breast and prostate cancer.
The research found that it was the CBD cannabinoid (cannabidiol) that was the best in stifling cancer – good news as it’s a non-psychoactive cannabinoid. CBD has been deemed effective as it has antitumor properties, including inhibiting activity in the IB-1 gene. Moreover, they can work alongside antitumor drugs a patient may already be taking.
However, the study made it clear that while the research was encouraging, it was far from conclusive and that there was still much progress needed to fully understand how CBD products could most efficiently be used to tackle the said illnesses.
Click here to find out more about the study.